Cheryl Belle
Adolescent Medicine · Richmond, VANPI 1255423448
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $494 and has fallen 92.1% since, to $39 in 2023.
Across 81 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$160
- Merck$128
- Amgen$125
- Novartis$103
- AbbVie$75
- AstraZeneca$73
- plus $755 from 23 others
What the payments were for
- Food & beverage$1,420100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 11 | $160 |
| Merck | 7 | $128 |
| Amgen | 8 | $125 |
| Novartis | 7 | $103 |
| AbbVie | 5 | $75 |
| AstraZeneca | 5 | $73 |
| Xeris Pharmaceuticals, Inc. | 3 | $70 |
| Bioventus LLC | 2 | $65 |
| Abbott | 3 | $65 |
| Sanofi-aventis U.S. LLC | 3 | $59 |
| Pacira Therapeutics, Inc. | 1 | $54 |
| Johnson & Johnson(2 entities) | 2 | $49 |
| Bayer | 3 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $43 |
| Lilly USA, LLC | 3 | $43 |
| Edwards Lifesciences | 2 | $34 |
| Astellas Pharma US Inc | 2 | $27 |
| Corium, LLC | 1 | $23 |
| Boehringer Ingelheim | 1 | $20 |
| Global Blood Therapeutics, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Lupin Inc. | 1 | $16 |
| Gilead | 1 | $14 |
| Insulet Corporation | 1 | $14 |
| Redhill Biopharma Inc. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Mylan Specialty L.p. | 1 | $11 |
How this compares
$1,420 in reported general payments places this provider in the 70th percentile of 49 adolescent medicine providers in Virginia.
Other adolescent medicine in Richmond
- Peter HeymanRichmond$3K
- Melani de SilvaRichmond$3K
- Charles TerryRichmond$2K
- Lora ChristianRichmond$2K
- Jocelyn VergaraRichmond$1K
- Cristi WilsonRichmond$216
- Stephanie CreweRichmond$124
- George RoweRichmond$102
- Adam FalikRichmond$82
- An PhamRichmond$76
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.